JMPWA
ANIK icon

JP Morgan Private Wealth Advisors’s Anika Therapeutics ANIK Stock Holding History

JP Morgan Private Wealth Advisors’s Portfolio ANIK Stock Details ANIK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		$338K Hold
18,141
– – ﹤0.01% 1414
2023
Q2 		$471K Hold
18,141
– – ﹤0.01% 1060
2023
Q1 		$521K Sell
18,141
-5,900
-25% -$176K ﹤0.01% 1464
2022
Q4 		$712K Hold
24,041
– – ﹤0.01% 1311
2022
Q3 		$572K Sell
24,041
-3,000
-11% -$69K ﹤0.01% 1400
2022
Q2 		$604K Sell
27,041
-11
-0% -$245 ﹤0.01% 1381
2022
Q1 		$679K Buy
27,052
+11
+0% +$335 ﹤0.01% 1389
2021
Q4 		$969K Hold
27,041
– – ﹤0.01% 1255
2021
Q3 		$1.15M Hold
27,041
– – ﹤0.01% 1150
2021
Q2 		$1.17M Sell
27,041
-2,999
-10% -$128K ﹤0.01% 1117
2021
Q1 		$1.23M Sell
30,040
-7,880
-21% -$299K ﹤0.01% 953
2020
Q4 		$1.72M Sell
37,920
-1,444
-4% -$54.8K 0.01% 797
2020
Q3 		$1.39M Buy
39,364
+15
+0% +$542 0.01% 761
2020
Q2 		$1.49M Buy
39,349
+82
+0.2% +$2.7K 0.01% 674
2020
Q1 		$1.14M Buy
39,267
+8
+0% +$324 0.01% 674
2019
Q4 		$2.04M Sell
39,259
-201
-0.5% -$11.7K 0.01% 614
2019
Q3 		$2.17M Sell
39,460
-1,389
-3% -$71.3K 0.01% 575
2019
Q2 		$1.66M Sell
40,849
-1,721
-4% -$62.8K 0.01% 626
2019
Q1 		$1.29M Buy
42,570
+3,892
+10% +$133K 0.01% 714
2018
Q4 		$1.3M Sell
38,678
-3,982
-9% -$144K 0.01% 675
2018
Q3 		$1.8M Buy
42,660
+492
+1% +$19.4K 0.01% 651
2018
Q2 		$1.35M Sell
42,168
-1,805
-4% -$74.3K 0.01% 689
2018
Q1 		$2.19M Buy
43,973
+1,283
+3% +$72.5K 0.01% 467
2017
Q4 		$2.3M Buy
42,690
+54
+0.1% +$2.99K 0.02% 458
2017
Q3 		$2.47M Buy
42,636
+2,064
+5% +$108K 0.02% 427
2017
Q2 		$2M Buy
40,572
+343
+0.9% +$15.8K 0.02% 459
2017
Q1 		$1.75M Buy
40,229
+7,404
+23% +$353K 0.01% 492
2016
Q4 		$1.61M Buy
32,825
+31
+0.1% +$1.43K 0.01% 478
2016
Q3 		$1.57M Hold
32,794
– – 0.01% 491
2016
Q2 		$1.76M Sell
32,794
-114
-0.3% -$5.37K 0.02% 472
2016
Q1 		$1.47M Sell
32,908
-832
-2% -$33.7K 0.01% 472
2015
Q4 		$1.29M Sell
33,740
-1,510
-4% -$57.8K 0.01% 465
2015
Q3 		$1.12M Hold
35,250
– – 0.01% 445
2015
Q2 		$1.16M Hold
35,250
– – 0.01% 475
2015
Q1 		$1.45M Hold
35,250
– – 0.02% 445
2014
Q4 		$1.44M Hold
35,250
– – 0.02% 446
2014
Q3 		$1.29M Hold
35,250
– – 0.02% 446
2014
Q2 		$1.63M Sell
35,250
-300
-0.8% -$13.3K 0.03% 327
2014
Q1 		$1.46M Hold
35,550
– – 0.03% 336
2013
Q4 		$1.36M Buy
35,550
+300
+0.9% +$9.26K 0.03% 304
2013
Q3 		$842K Hold
35,250
– – 0.02% 355
2013
Q2 		$599K Buy
+35,250
New +$508K 0.01% 390

Other funds holding ANIK

TI
Trigran Investments Northbrook, Illinois $545M AUM 56.2% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CP
Caligan Partners New York $1.5B AUM 518.95% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.29% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

JP Morgan Private Wealth Advisors's ANIK Position: Q3 2023 in Review

JP Morgan Private Wealth Advisors held its Anika Therapeutics (ANIK) position steady in Q3 2023 at 18,141 shares worth $338K. The position accounts for ﹤0.01% of the portfolio, ranked #1414.

JP Morgan Private Wealth Advisors first reported a position in ANIK in Q2 2013 and has held it in 42 quarters since. The position peaked at $2.47M in Q3 2017. 116 funds tracked by Wall St. Rank hold ANIK as of Q3 2023.

  • JP Morgan Private Wealth Advisors held 18,141 shares of Anika Therapeutics worth $338K as of Q3 2023.
  • JP Morgan Private Wealth Advisors left its Anika Therapeutics share count unchanged in Q3 2023.
  • Anika Therapeutics made up ﹤0.01% of JP Morgan Private Wealth Advisors's portfolio in Q3 2023, its #1414 holding.
  • JP Morgan Private Wealth Advisors first reported a position in Anika Therapeutics in Q2 2013 and has held it in 42 quarters since.
  • JP Morgan Private Wealth Advisors's Anika Therapeutics position peaked at $2.47M in Q3 2017.
  • 116 funds tracked by Wall St. Rank held Anika Therapeutics as of Q3 2023.

Based on JP Morgan Private Wealth Advisors's 13F filing for Q3 2023, filed 8 Nov 2023.